entinostat has been researched along with Granulocytic Leukemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conte, M | 1 |
Dell'Aversana, C | 1 |
Benedetti, R | 1 |
Petraglia, F | 1 |
Carissimo, A | 1 |
Petrizzi, VB | 1 |
D'Arco, AM | 1 |
Abbondanza, C | 1 |
Nebbioso, A | 1 |
Altucci, L | 1 |
Gaymes, TJ | 1 |
Shall, S | 1 |
MacPherson, LJ | 1 |
Twine, NA | 1 |
Lea, NC | 1 |
Farzaneh, F | 1 |
Mufti, GJ | 1 |
Blum, W | 1 |
Marcucci, G | 1 |
Horita, H | 1 |
Frankel, AE | 1 |
Thorburn, A | 1 |
1 review available for entinostat and Granulocytic Leukemia
Article | Year |
---|---|
Targeting epigenetic changes in acute myeloid leukemia.
Topics: Acetylation; Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Depsipeptide | 2005 |
3 other studies available for entinostat and Granulocytic Leukemia
Article | Year |
---|---|
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape.
Topics: Acute Disease; Aged; Benzamides; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Female; Ge | 2015 |
Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes.
Topics: Apoptosis; Azacitidine; Benzamides; Butyrates; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Surviva | 2009 |
Acute-myeloid-leukemia-targeted toxins kill tumor cells by cell-type-specific mechanisms and synergize with TRAIL to allow manipulation of the extent and mechanism of tumor cell death.
Topics: Acute Disease; Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Benzamides; Caspas | 2008 |